Notably, a few surface molecules enriched in M01/M03 among the top 10 surface markers correspond to drug targets in the BindingDB, including CCR1, FPR1, and GPR183. FPR1 was higher in the severe COVID-19 group than in the healthy control and moderate groups (Fig. 3c). This evidence concerns the gene GPR183 and COVID-19.